News

Each unit consists of one common share plus one-half common share purchase warrant. Each whole common share purchase warrant will enable the holder to purchase one common share

Pursuant to the terms of the agreement, FirstPoint Biotech (FPBT) will have the responsibility to undertake the clinical development and commercialization of these compounds within these fields of

This 17-day study was designed to test the efficacy of CH-4051 in a rat collagen-induced arthritis model. The results reveal a remarkable level of efficacy in delaying the

The OptiQual Methicillin Resistant Staphylococcus aureas (MRSA) Positive Control may be used to independently monitor all phases of MRSA DNA testing to ensure consistent and accurate results. Each

The agreements, which are effective on May 1, 2008, name Smiths Medical as a supplier for anesthesia products and make the company’s line of anesthesia products available to

As per this agreement, earnings will accrue to the benefit of Cardiovascular Sciences. Eric Edelmann, president of Medical technologies, said: “With all the recent advances and impressive data

Brown Cancer Center researchers Robert Mitchell and John Trent discovered that 4-IPP, a novel small molecule compound, exhibits anti-tumor activity by blocking tumor-specific angiogenesis, and thus far has

Versant Ventures led the financing and Olympus Medical Systems, New Enterprise Associates, New Leaf Venture Partners (Sprout Group), InterWest Partners, Investor Growth Capital and Three Arch Partners also

APP’s cefepime is AP-rated, bar-coded and latex-free. Cefepime hydrochloride for injection is indicated in the treatment of the following infections: pneumonia, empiric therapy for febrile neutropenic patients, urinary